BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 16361804)

  • 21. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
    Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
    Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CLINICO-MICROBIOLOGICAL CHARACTERISTICS OF MYCOBACTERIUM KANSASII PULMONARY DISEASE AT A SPECIALIZED MYCOBACTERIOSIS HOSPITAL IN TOKYO, JAPAN].
    Morimoto K; Maeda S; Yoshiyama T; Matsuda S; Uchimura K; Sasaki Y; Kurashima A; Ogata H; Kudoh S; Gotoh H
    Kekkaku; 2015 Apr; 90(4):453-6. PubMed ID: 26489147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N; Saba R; Maddika S; Weinstein M
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathogenicity of Mycobacterium kansasii].
    Vesenbeckh S; Wagner S; Mauch H; Roth A; Streubel A; Rüssmann H; Bauer TT; Matthiessen W; Schönfeld N
    Pneumologie; 2014 Aug; 68(8):526-31. PubMed ID: 25046682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
    Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
    Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Three cases of Mycobacterium kansasii pulmonary diseases in previously healthy young women].
    Ohnishi T; Kusumoto S; Yamaguchi S; Ohki Y; Satou M; Sugiyama T; Shirai T; Nakashima M; Yamaoka T; Okuda K; Hirose T; Adachi M
    Nihon Kokyuki Gakkai Zasshi; 2011 Jun; 49(6):426-31. PubMed ID: 21735743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium kansasii infections in patients with cancer.
    Jacobson KL; Teira R; Libshitz HI; Raad I; Rolston KV; Terrand J; Whimbey E
    Clin Infect Dis; 2000 Aug; 31(2):628-31. PubMed ID: 10987747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium kansasii infections in patients with cancer.
    Jacobson KL; Teira R; Libshitz HI; Raad I; Rolston KV; Tarrand J; Whimbey E
    Clin Infect Dis; 2000 Jun; 30(6):965-9. PubMed ID: 10880318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
    Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
    Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
    Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
    J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature.
    Cho JH; Yu CH; Jin MK; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim CD; Kim YL
    Transpl Infect Dis; 2012 Oct; 14(5):E50-5. PubMed ID: 22823928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparison of chest radiographs between patients with pulmonary Mycobacterium kansasii infection and those with Mycobacterium tuberculosis infection in the initial stage of disease].
    Inoue E; Senoo M; Nagayama N; Masuda K; Matsui H; Tamura A; Nagai H; Akagawa S; Toyoda E; Oota K
    Kekkaku; 2013 Aug; 88(8):619-23. PubMed ID: 24044165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and epidemiological characteristics of M. kansasii pulmonary infections from Rio de Janeiro, Brazil, between 2006 and 2016.
    Goldenberg T; Gayoso R; Mogami R; Lourenço MC; Ramos JP; Carvalho LD; Dalcolmo MP; Mello FCQ
    J Bras Pneumol; 2020; 46(6):e20190345. PubMed ID: 32696934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.
    Hoefsloot W; van Ingen J; Andrejak C; Angeby K; Bauriaud R; Bemer P; Beylis N; Boeree MJ; Cacho J; Chihota V; Chimara E; Churchyard G; Cias R; Daza R; Daley CL; Dekhuijzen PN; Domingo D; Drobniewski F; Esteban J; Fauville-Dufaux M; Folkvardsen DB; Gibbons N; Gómez-Mampaso E; Gonzalez R; Hoffmann H; Hsueh PR; Indra A; Jagielski T; Jamieson F; Jankovic M; Jong E; Keane J; Koh WJ; Lange B; Leao S; Macedo R; Mannsåker T; Marras TK; Maugein J; Milburn HJ; Mlinkó T; Morcillo N; Morimoto K; Papaventsis D; Palenque E; Paez-Peña M; Piersimoni C; Polanová M; Rastogi N; Richter E; Ruiz-Serrano MJ; Silva A; da Silva MP; Simsek H; van Soolingen D; Szabó N; Thomson R; Tórtola Fernandez T; Tortoli E; Totten SE; Tyrrell G; Vasankari T; Villar M; Walkiewicz R; Winthrop KL; Wagner D;
    Eur Respir J; 2013 Dec; 42(6):1604-13. PubMed ID: 23598956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cavitary lung lesions due to coinfection of Rhodococcus equi and Mycobacterium kansasii in a patient with acquired immunodeficiency syndrome.
    Patel S; Wolf T
    Am J Med; 2002 Jun; 112(8):678-80. PubMed ID: 12034423
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
    Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist's view.
    Winthrop KL
    Future Microbiol; 2010 Mar; 5(3):343-5. PubMed ID: 20210543
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycobacterium shimoidei, a Rare Pulmonary Pathogen, Queensland, Australia.
    Baird TM; Carter R; Eather G; Thomson R
    Emerg Infect Dis; 2017 Nov; 23(11):1919-1922. PubMed ID: 29048290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.